RBM39 is a coactivator of ER, ER, and Activator Protein‐1 (AP‐1) component c‐Jun, which binds transcription and mRNA precursor processing together and effectively boosts their transcriptional activity, hence encouraging breast cancer growth.17 This evidence concerns the gene JUN and breast carcinoma.